Summit Therapeutics Inc (NAS:SMMT)
$ 4.685 -0.115 (-2.4%) Market Cap: 3.29 Bil Enterprise Value: 3.32 Bil PE Ratio: 0 PB Ratio: 78.08 GF Score: 50/100

Summit Therapeutics Inc (SMMT) Stock Estimates Data

Summit Therapeutics Inc (SMMT) 12 Month Price Targets

Summit Therapeutics Inc (SMMT) Analyst Rating